Article published In:
Information Design Journal
Vol. 21:3 (2014) ► pp.225243
References
Ben-Shahar, O. Schneider, C.E
(2011) The failure of mandatory disclosure. University of Pennsylvania Law Review, 1591, 647–749.Google Scholar
Bergus, G. R., Levin, I. P., & Elstein, A. S
(2002) Presenting risks and benefits to patients, Journal of General Internal Medicine, 17(8), 612–617. DOI logoGoogle Scholar
Berry, D.C., Knapp, P.R, & Raynor, D.K
(2002) Is 15% very common? Informing people about the risks of medication side effects. International Journal of Pharmacy Practice, 101, 145–151. DOI logoGoogle Scholar
Berry, D. C., Raynor, D. K., & Knapp, P
(2003) Communicating risk of medication side effects: An empirical evaluation of EU recommended terminology. Psychology, Health and Medicine, 8(3), 251–263. DOI logoGoogle Scholar
Berry, D., Raynor, T., Knapp, P., & Bersellini, E
(2004) Over the counter medicines and the need for immediate action: A further evaluation of European commission recommended wordings for communicating risk. Patient Education and Counseling, 53(2), 129–134. DOI logoGoogle Scholar
Clerehan, R., Buchbinder, R., & Moodie, J
(2005) A linguistic framework for assessing the quality of written patient information: its use in assessing methotrexate information for rheumatoid arthritis. Health Education Research, 20(3): 334–344. DOI logoGoogle Scholar
Dickinson, R., Hamrosi, K., Knapp, P., Aslani, P., Sowter, J., Krass, I., & Raynor, D. K
(2013) Suits you? A qualitative study exploring preferences regarding the tailoring of consumer medicines information. International Journal of Pharmacy Practice, 21(4), 207–215. DOI logoGoogle Scholar
Dost, D
(2014) Lees voor gebruik de bijsluiter. De invloed van kopjes en structuur op de begrijpelijkheid van de geneesmiddelenbijsluiter. (Bachelor Thesis). Retrieved from [URL]
European Commission
(2009) Guideline on the readability of the labelling and package leaflet of medicinal products for human use. (ENTR/F/2/SF/jr (2009)D/869). Brussels.
European Medicines Agency—EMA
(2013) Quality Review of Documents human product-information annotated template (English) version 9.
Hirsh, D., Clerehan, R., Staples, M., Osborne, R. H., & Buchbinder, R
(2009) Patient assessment of medication information leaflets and validation of the evaluative linguistic framework (ELF). Patient Education and Counseling, 77(2), 248–254. DOI logoGoogle Scholar
Isaacson, J.J., Altman Klein, H., & Muldoon, R.V
(1999) Prescription medication information: improving usability through human factors design. Proceedings of the Human Factors and Ergonomics Society Annual Meeting , 431, 873–877.
Kiesler, D. J., & Auerbach, S. M
(2006) Optimal matches of patient preferences for information, decision-making and interpersonal behavior: evidence, models and interventions. Patient education and counseling, 61(3), 319–341. DOI logoGoogle Scholar
Knapp, P., Berry, D.C., & Raynor, D.K
(2001) Testing two methods of presenting side effect risk information about common medicines. International Journal of Pharmacy Practice, 9 (suppl.), R6. DOI logoGoogle Scholar
Knapp, P., Raynor, D. K., & Berry, D. C
(2004) Comparison of two methods of presenting risk information to patients about the side effects of medicines. Quality and Safety in Health Care, 13(3), 176–180. DOI logoGoogle Scholar
Lentz, L.R. & Pander Maat, H.L.W
(1994) Patient information leaflets: a functional content analysis and an evaluation study. In P. van den Hoven, E. Woudstra & L. van Waes (Eds.), Functional Communication Quality (pp. 137–148). Amsterdam, Rodopi.Google Scholar
Meijer, A., Grimmelikhuijsen, S., Nell, M.L., & Lentz, L
(2014) Organizational arrangements for targeted transparency. Legal or communicative enactment of disclosure requirements. Information Polity, 19(1–2), 115–127. DOI logoGoogle Scholar
Morrow, D.G., Leirer, V.O., Andrassy, J.M., Tanke, E.D., & Stine-Morrow, E.A.L
(1996) Medication instruction design: Younger and older adult schemas for taking medication. Human Factors, 38(4), 556–573. DOI logoGoogle Scholar
Morrow, D.G., Leirer, V.O., Andrassy, J.M., Hier, C.M., & Menard, W.E
(1998) The influence of list format and category headers on age differences in understanding medication instructions. Experimental Aging Research, 24(3), 231–256. DOI logoGoogle Scholar
Nink, K. & Schröder, H
(2005) Zu Risiken und Nebenwirkungen: Lesen Sie die Packungsbeilage? Bonn: Wissenschaftliches Institut der AOK (WIdO).
Pander Maat, H., & Lentz, L
(2010) Improving the usability of patient information leaflets. Patient Education and Counseling, 801, 113–119. DOI logoGoogle Scholar
(2011) Using sorting data to evaluate text structure: an evidence-based proposal for restructuring patient information leaflets. Technical Communication, 58(3), 218–237.Google Scholar
Pander Maat, H., Lentz, L., & Raynor, D.K
(2015) Testing templates for texts: the case of European patient information leaflets for medicines. Manuscript submitted for publication.
Papay, J.I., Fritz, D., Cantu, T., Ellis, M., & Debussey, S
(2010) Assessment of a simplified format of written patient prescription drug information. Drug Information Journal, 44(4), 375–391. DOI logoGoogle Scholar
Raynor, D.K., & Dickinson, D
(2009) Key principles to guide development of consumer medicine information – Content analysis of information design texts. The Annals of Pharmacotherapy, 43(4), 700–706. DOI logoGoogle Scholar
Schommer, J.C., Doucette, W.C., & Worley, M.M
(2001) Processing prescription drug information under different conditions of presentation. Patient Education and Counseling, 431, 49–59. DOI logoGoogle Scholar
Sless, D. & Shrensky, R
(2006) Writing about medicines for people. Usability guidelines for consumer medication information. Communication Research Institute. Canberra. Third edition.
Sweller, J
(1994) Cognitive load theory, learning difficulty, and instructional design. Learning and Instruction, 41, 295–312. DOI logoGoogle Scholar
Wilson, E.A.H., & Wolf, M.S
(2009) Working memory and the design of health materials: A cognitive factors perspective. Patient Education and Counseling, 74(3), 318–322. DOI logoGoogle Scholar
Wolf, A., Fuchs, J., & Schweim, H.J
(2012) QRD Template Texts Intended for Package Inserts. Development from the first QRD template up to the new draft of July 2012. Die Pharmazeutische Industrie, 74(9), 1540–1549.Google Scholar
Wright, P
(1999) Writing and information design of healthcare materials. In: Candlin, C. & Hyland, K. (Eds.). Writing: Texts, Processes and Practices. Longman, London, 85–95.Google Scholar
Cited by

Cited by 4 other publications

Meloncon, Lisa K.
2017. Patient experience design. Communication Design Quarterly 5:2  pp. 19 ff. DOI logo
Pander Maat, Henk, Leo Lentz, David K. Raynor & Francesco Pappalardo
2015. How to Test Mandatory Text Templates: The European Patient Information Leaflet. PLOS ONE 10:10  pp. e0139250 ff. DOI logo
Carla Galvão Spinillo, Amanda Rutiquewiski Gomes & Larissa Yumi Asami
2017. Blucher Design Proceedings,  pp. 1997 ff. DOI logo
Walker, Sue, Manjula Halai, Rachel Warner & Josefina Bravo
2021. Beat Bad Microbes. Information Design Journal 26:1  pp. 17 ff. DOI logo

This list is based on CrossRef data as of 1 june 2024. Please note that it may not be complete. Sources presented here have been supplied by the respective publishers. Any errors therein should be reported to them.